• Most Popular
  • Most Shared

Amicus Therapeutics sets IPO at 5 million shares

Thu May 17, 2007 6:39am EDT

Stocks

   

Regulatory News  |  IPOs

WASHINGTON, May 17 (Reuters) - Biopharmaceutical firm Amicus Therapeutics Inc. on Thursday set its planned initial public offering at 5 million shares for an estimated $14 to $16 each.

Morgan Stanley, Merrill Lynch & Co., JPMorgan, Lazard Capital Markets, and Pacific Growth Equities LLC are underwriting the IPO, according to an amended filing with the U.S. Securities and Exchange Commission.

Amicus intends to list its stock on the Nasdaq under the symbol "FOLD." (FOLD.O)

((Reporting by Karey Wutkowski, Reuters Messaging: karey.wutkowski.reuters.com@reuters.net; E-mail:karey.wutkowski@reuters.com +1 202 898 8399)) Keywords: AMICUS IPO/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN17265013
Regulatory News
IPOs


More from Reuters

Photo

New security restrictions could hurt airlines

NEW YORK (Reuters) - Tighter security measures at U.S. airports following an attempt to blow up a Detroit-bound jet could dampen enthusiasm for air travel, hurting the airline industry just as it seemed poised to recover from a period of bruising losses, some industry experts say.

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets